DXR - DAXOR CORP


9.95
0.290   2.915%

Share volume: 21,774
Last Updated: 05-08-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%

$9.66
0.29
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
12%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 30%
Performance
5 Days
-8.33%
1 Month
5.12%
3 Months
-18.44%
6 Months
-22.27%
1 Year
37.05%
2 Year
4.16%
Key data
Stock price
$9.95
P/E Ratio 
0.00
DAY RANGE
$9.75 - $10.41
EPS 
N/A
52 WEEK RANGE
$7.19 - $14.76
52 WEEK CHANGE
$37.05
MARKET CAP 
40.872 M
YIELD 
N/A
SHARES OUTSTANDING 
4.837 M
DIVIDEND
$0.03
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
-0.15
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$10,052
AVERAGE 30 VOLUME 
$7,605
Company detail
CEO: Michael R. Feldschuh
Region: US
Website: daxor.com
Employees: 37
IPO year: 1992
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Daxor Corporation provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition.

Recent news